Connection

Kenneth Spicer to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Kenneth Spicer has written about Radiopharmaceuticals.
Kenneth Spicer
Connection Strength
0.466
Radiopharmaceuticals
  1. Paradoxical hyperfixation of HMPAO in cerebral infarction. AJNR Am J Neuroradiol. 1999 May; 20(5):732-3.
    View in: PubMed
    Score: 0.159
  2. Octreotide uptake in the head and neck. Semin Nucl Med. 1997 Jan; 27(1):79-81.
    View in: PubMed
    Score: 0.135
  3. Comparison of medium- and high-energy collimators for 131I-tositumomab dosimetry. J Nucl Med Technol. 2007 Sep; 35(3):148-53.
    View in: PubMed
    Score: 0.071
  4. Cholecystokinin-Stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol. 2001 Nov; 96(11):3106-9.
    View in: PubMed
    Score: 0.047
  5. Ultratag RBC kit for combined cardiac first-pass and multigated acquisition studies. J Nucl Med Technol. 1997 Mar; 25(1):44-8.
    View in: PubMed
    Score: 0.034
  6. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol. 2009 Sep-Oct; 16(5):801-10.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.